ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2026, Vol. 35 ›› Issue (4): 363-368.DOI: 10.3969/j.issn.1006⁃298X.2026.04.013

• 肾脏病基础 • 上一篇    下一篇

线粒体 DNA 损伤在糖尿病肾脏疾病中的研究进展

  

  • 出版日期:2026-08-28 发布日期:2026-08-31

Advances in mitochondrial DNA damage in diabetic kidney disease

  • Online:2026-08-28 Published:2026-08-31

摘要:

线粒体功能障碍是糖尿病肾脏疾病 (DKD) 的核心病理环节之一。线粒体 DNA (mtDNA) 作为线粒体的关键遗传物质,其损伤在 DKD 进展中发挥重要作用。本综述系统阐述了高血糖、氧化应激、脂毒性及线粒体动力学异常等因素诱导 mtDNA 损伤的机制,并以肾脏固有细胞为切入点,重点论述 mtDNA 损伤通过引发能量代谢紊乱、加剧氧化应激、诱导细胞凋亡、激活炎症反应及干扰线粒体自噬等途径驱动 DKD 进展的分子机制。此外,本文总结了以 mtDNA 为靶点的治疗新策略,探讨了外周血及尿液中 mtDNA 拷贝数作为 DKD 无创性生物标志物的潜力及挑战,以期为 DKD 的防治提供新思路和理论依据。 

关键词: 糖尿病肾脏疾病, 线粒体 DNA, 生物标志物

Abstract: Mitochondrial dysfunction is one of the central pathologic links in diabetic kidney disease (DKD). As the crucial genetic material of mitochondria, mitochondrial DNA (mtDNA) damage plays a significant role in the progression of DKD. This review systematically elaborates on the mechanisms by which hyperglycemia, oxidative stress, lipotoxicity, and mitochondrial dynamics abnormalities induce mtDNA damage under DKD conditions. Focusing on renal intrinsic cells, it highlights the molecular mechanisms through which mtDNA damage drives DKD progression, including disruptions in energy metabolism, exacerbation of oxidative stress, induction of apoptosis, activation of inflammatory responses, and interference with mitophagy. Furthermore, this article summarizes current therapeutic strategies targeting mtDNA, and discusses the potential and challenges of using mtDNA copy number in peripheral blood or urine as a non⁃invasive biomarker for DKD, aiming to provide new insights and a theoretical basis for the prevention and treatment of DKD.